PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019)

Record Type:: Journal Article
Title:: PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (12th June 2019)
Main Title:: PORTIA: A PHASE 1B STUDY EVALUATING SAFETY AND EFFICACY OF TISAGENLECLEUCEL AND PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA
Authors:: Jaeger, U.
McGuirk, J.
Worel, N.
Riedell, P.
Fleury, I.
Borchmann, P.
Forcina, A.
Chu, J.
Leung, M.
Pacaud, L.
Waller, E.
Abstract:
Is Part Of:: Hematological oncology. Volume 37(2019)Supplement 2
Journal:: Hematological oncology
Issue:: Volume 37(2019)Supplement 2
Issue Display:: Volume 37, Issue 2 (2019)
Year:: 2019
Volume:: 37
Issue:: 2
Issue Sort Value:: 2019-0037-0002-0000
Page Start:: 560
Page End:: 560
Publication Date:: 2019-06-12
Subjects:: Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:: http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1002/hon.7_2632 ↗
Languages:: English
ISSNs:: 0278-0232
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 12428.xml